Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372324
Max Phase: Preclinical
Molecular Formula: C50H72N14O12S2
Molecular Weight: 1125.35
Molecule Type: Unknown
Associated Items:
ID: ALA2372324
Max Phase: Preclinical
Molecular Formula: C50H72N14O12S2
Molecular Weight: 1125.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1ccc(C[C@@H]2NC(=O)CC(C)(C)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C50H72N14O12S2/c1-4-76-30-16-14-29(15-17-30)23-33-44(71)61-34(22-28-10-6-5-7-11-28)45(72)59-32(18-19-38(51)65)43(70)62-35(24-39(52)66)46(73)63-36(27-77-78-50(2,3)25-41(68)58-33)48(75)64-21-9-13-37(64)47(74)60-31(12-8-20-56-49(54)55)42(69)57-26-40(53)67/h5-7,10-11,14-17,31-37H,4,8-9,12-13,18-27H2,1-3H3,(H2,51,65)(H2,52,66)(H2,53,67)(H,57,69)(H,58,68)(H,59,72)(H,60,74)(H,61,71)(H,62,70)(H,63,73)(H4,54,55,56)/t31-,32-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: DXUVFMUKUWRNFX-PEAOEFARSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1125.35 | Molecular Weight (Monoisotopic): 1124.4896 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.. (1985) Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin., 28 (10): [PMID:4045923] [10.1021/jm00148a019] |
Source(1):